Floatz logo

mb07133

MTD

Xi'an Xintong Pharmaceutical Research Co.,Ltd.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the MTD cohort.

Asset / SponsorPhaseRating
ibd0333
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2CCC

Same molecule, other indications

mb07133 is also rated in:

Safety IssuesDormant
B
Indicative ·
60 / 100
View asset →
ToleranceDormant
CCC
Indicative ·
53 / 100
View asset →
EfficacyDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →